Completed PHASE4 INTERVENTIONAL 2-arm NCT02215382

Intraocular Pressure Changes Associated With Tracheal Extubation: Comparison of Sugammadex With Conventional Reversal of Neuromuscular Blockade

Sponsor: Ordu University

Conditions Intraocular Pressure Changes During Tracheal Extubation

Interventions neostigmine+atropine sugammadex

Updated 7 times since 2017 Last updated: Apr 18, 2015 Started: Aug 31, 2014 Primary completion: Oct 31, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02215382, this PHASE4 trial focuses on Intraocular Pressure Changes During Tracheal Extubation and remains completed. Sponsored by Ordu University, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Nov 2025 — Present [monthly]

Completed PHASE4
Sep 2025 — Nov 2025 [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ordu University

Data source: Ordu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Altinordu, Turkey (Türkiye)